Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors.

Mediterr J Rheumatol

Departments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, United Kingdom.

Published: June 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450206PMC
http://dx.doi.org/10.31138/mjr.33.2.173DOI Listing

Publication Analysis

Top Keywords

hyperinflammation covid-19
4
covid-19 targeted
4
targeted interleukin-1
4
interleukin-1 inhibitors
4
hyperinflammation
1
targeted
1
interleukin-1
1
inhibitors
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!